
RIBT does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RIBT and 80,000+ other tickers.
See exactly how RIBT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RIBT and 80,000+ other tickers.
RiceBran Technologies, along with its associated companies, functions as a specialized purveyor of ingredients. Its core business revolves around the development, processing, and distribution of premium, wholesome, and nutrient-rich products, sourced primarily from rice and other select small grains. The company adeptly transforms raw rice bran into stabilized rice bran (SRB) and subsequently into a suite of high-value derivative products. These include RiBalance, a comprehensive nutritional offering created by refining SRB; RiSolubles, a carbohydrate and lipid-dense fraction extracted from…

SeoulCeuticals publishes a sourcing guide to four Korean heritage ingredients, Panax Ginseng, Rice Bran, Snail Mucin, and PDRN as industry analysts identify hanbang modernization as 2026's defining K-beauty trend, backed by peer-reviewed clinical research. Palm Beach, Florida--(Newsfile Corp. - March 3, 2026) - Korean-inspired skincare brand SeoulCeuticals announced Tuesday its position as one of the few US-based brands sourcing Panax Ginseng Extract, Rice Bran, Snail Mucin, and PDRN directly from South Korea while manufacturing in US facilities.

Asset Divestiture Further Streamlines Business as Part of Strategic Process TOMBALL, TX / ACCESSWIRE / January 26, 2024 / RiceBran Technologies (OTC PINK:RIBT) ("RiceBran" or the "Company"), today announced that it has sold its Golden Ridge rice mill located in Wynne, Arkansas for $2.15 million. The divestiture is expected to, based upon third quarter 2023 results, further narrow RiceBran's projected annual net loss by approximately $1.5 million while not jeopardizing the estimated $54.4 million in federal and $46.0 million in state net operating loss carryforwards that the Company had amassed as of December 31, 2022.

Experienced Investors Georgina Russell and James Flynn Join Board of Directors to Advance Strategic Review TOMBALL, TX / ACCESSWIRE / January 4, 2024 / RiceBran Technologies (OTC PINK:RIBT) ("RiceBran" or the "Company"), today announced that James Flynn and Georgina Russell have been appointed to the Company's Board of Directors. Both Mr. Flynn and Ms.

Board continues to review strategic initiatives and alternatives TOMBALL, TX / ACCESSWIRE / December 20, 2023 / RiceBran Technologies (OTCMKTS:RIBT) ("RiceBran" or the "Company"), an innovator in the development and manufacture of nutritional and functional ingredients derived from rice, barley and oats, today announced financial results for the third quarter ended September 30, 2023. Eric Tompkins, Executive Chairman of RiceBran, commented, "The Board of Directors continues to advance a strategic review, with the goal of creating a more sustainable organization that can better capitalize on the benefits of a public listing and the significant carryforward tax assets that have been accumulated.

Cash investment of $4 million for new debt, equity and warrants Company repaid term loan and exchanged prior warrants for stock and new warrants Transactions provide stability to advance strategic process TOMBALL, TX / ACCESSWIRE / December 4, 2023 / RiceBran Technologies (OTCMKTS:RIBT) ("RiceBran" or the "Company"), an innovator in the development and manufacture of nutritional and functional ingredients derived from rice, barley and oats, today announced a series of transactions to provide working capital, refinance certain of its prior debt and exchange certain warrants for shares of common stock, no par value ("Common Stock"), and new warrants in the Company, creating a more stable and sustainable foundation as the Board of Directors continues to explore strategic initiatives and alternatives to maximize value of its assets and public platform. Key elements of the transactions include: Investment by Funicular Funds, LP A fund managed by Cable Car Capital LLC, Funicular Funds, LP ("Funicular"), has purchased $400,000 in shares of Common Stock at a per share price of $0.18, representing approximately 2.2 million shares.